Magangcong, Asnia P.

HRN: 27-44-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFTRIAXONE 1G (VIAL)
12/27/2025
01/02/2026
IV
2g
OD
UTI
Checking Initial Appropriateness 
01/03/2026
CEFUROXIME 500MG (TAB)
01/03/2026
01/09/2026
ORAL
500mg
BID
UTI
Checking Final Appropriateness 
01/08/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/08/2026
01/15/2026
IV
4.5g
Q8
UTI, IV Site Phlebitis, (DM Pt)
Checking Initial Appropriateness 
01/13/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/13/2026
01/20/2026
IV
750mg
OD
UTI; Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: